Pentatricopeptide repeat domain 2 pseudogene 2 (PTCD2P2)

PTCD2P2 (Pentatricopeptide repeat domain 2 pseudogene 2) is classified as a human pseudogene. Pseudogenes are DNA sequences similar to functional genes but generally lack the ability to encode functional proteins due to mutations or loss of regulatory regions. They are usually considered transcriptionally inactive, but some pseudogenes can be transcribed into non-coding RNAs that may play regulatory roles in gene expression. Large systematic studies of pseudogenes have identified that some are transcribed with tissue specificity and may act as competing endogenous RNAs or modulators of parent gene expression by acting as miRNA decoys or sources of small regulatory RNAs; however, PTCD2P2 itself has not been specifically characterized as having such activity in the published literature[1][2][3]. It is not used as a drug target, does not code for a receptor or enzyme, and is not recognized as a biomarker or therapeutic target. There is no literature evidence to indicate that "Pentatricopeptide repeat domain 2 pseudogene 2" (PTCD2P2) is a therapeutically actionable or functionally relevant gene product. The abbreviation and full name given are consistent, but this is not a gene or protein that would be the target of a drug or considered a classic receptor, enzyme, transporter, or transcription factor. The target is therefore not applicable as a therapeutic target and inclusion in target lists is erroneous[1][2][3].

Other names

PTCD2 pseudogene 2PTCD2P2